Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
Ocular Therapeutix (OCUL) Ownership - Who Owns Ocular Therapeutix?
1,367 Followers
Ocular Therapeutix (OCUL) Ownership Overview
14.36% Insiders
8.01% Mutual Funds
13.64% Other Institutional Investors
63.99% Public Companies and Individual Investors
The ownership structure of Ocular Therapeutix (OCUL) stock is a mix of institutional, retail and individual investors. Approximately 21.65% of the company’s stock is owned by Institutional Investors, 14.36% is owned by Insiders and 63.99% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 28, 2024 | Sanjay Nayak Cso | xxxxxxxxxxxxx | $13280 |
| May 28, 2024 | Pravin Dugel Executive Chairman, President And Ceo,director | xxxxxxxxxxxxx | $125215 |
| Feb 27, 2024 | Summer Road Llc >10% Owner | xxxxxxxxxxxxx | $7000000 |
| Feb 06, 2024 | xxxxxxxxxxxxx | $28723 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $139339 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $289853 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $30252658 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,038,735 | Institution | 5.19% | 63,104,070 | |
| 6,276,335 | Institution | 4.05% | 49,269,230 | |
| 6,212,336 | Institution | 4.01% | 48,766,838 | |
| 3,324,468 | Institution | 2.15% | 26,097,074 | |
| 3,014,973 | Insider | 1.95% | 23,667,538 | |
| 2,296,259 | Institution | 1.48% | 18,025,633 | |
| 2,215,384 | Insider | 1.43% | 17,390,764 | |
| 1,717,308 | Institution | 1.11% | 13,480,868 | |
| 1,221,808 | Institution | 0.79% | 9,591,193 | |
| 864,749 | Institution | 0.56% | 6,788,280 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,212,336 | Institution | 4.01% | 48,766,838 | |
| 1,717,308 | Institution | 1.11% | 13,480,868 | |
| 1,221,808 | Institution | 0.79% | 9,591,193 | |
| 864,749 | Institution | 0.56% | 6,788,280 | |
| 750,100 | Institution | 0.48% | 5,888,285 | |
| 368,117 | Institution | 0.24% | 2,889,718 | |
| 221,202 | Institution | 0.14% | 1,736,436 | |
| 140,000 | Institution | 0.09% | 1,099,000 | |
| 117,658 | Institution | 0.08% | 923,615 | |
| 94,601 | Institution | 0.06% | 742,618 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,140,555 | Institution | 2.67% | 32,503,357 | |
| 4,517,530 | Institution | 2.92% | 30,899,905 | |
| 2,380,438 | Institution | 1.54% | 16,282,196 | |
| 1,389,145 | Institution | 0.90% | 10,904,788 | |
| 741,000 | Institution | 0.48% | 5,742,750 | |
| 741,000 | Institution | 0.48% | 5,742,750 | |
| 654,125 | Institution | 0.42% | 5,069,469 | |
| 579,309 | Institution | 0.37% | 3,962,474 | |
| 351,143 | Institution | 0.23% | 2,756,473 | |
| 338,344 | Institution | 0.22% | 2,314,273 |
FAQ
Who Owns Ocular Therapeutix (OCUL)?
According to the latest TipRanks data, approximately 13.64% of the company's stock is held by institutional investors, 14.36% is held by insiders, and 63.99% is held by retail investors.
What percentage of Ocular Therapeutix (OCUL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.64% of Ocular Therapeutix (OCUL) stock is held by institutional investors.
What percentage of Ocular Therapeutix (OCUL) stock is held by retail investors?
According to the latest TipRanks data, approximately 63.99% of Ocular Therapeutix (OCUL) stock is held by retail investors.
Who owns the most shares of Ocular Therapeutix (OCUL)?
Vanguard owns the most shares of Ocular Therapeutix (OCUL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.